clarithromycin has been researched along with ranalexin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cirioni, O; D'Errico, MM; Del Prete, MS; Giacometti, A; Paggi, AM; Scalise, G | 1 |
Barchiesi, F; Cirioni, O; Giacometti, A; Scalise, G | 1 |
2 other study(ies) available for clarithromycin and ranalexin
Article | Year |
---|---|
Combination studies between polycationic peptides and clinically used antibiotics against Gram-positive and Gram-negative bacteria.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Clarithromycin; Colistin; Doxycycline; Drug Interactions; Drug Resistance, Multiple; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Lactams; Magainins; Molecular Sequence Data; Peptides; Peptides, Cyclic; Proteins; Pseudomonas aeruginosa; Staphylococcus aureus; Xenopus Proteins | 2000 |
In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Interactions; Humans; Imipenem; Methicillin Resistance; Nisin; Peptides, Cyclic; Rana catesbeiana; Rifampin; Staphylococcus aureus; Vancomycin | 2000 |